Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Colorado
Lobbyists on this filing
1
-
JASON FRYEPreviously held: Tom Emmer MN-06 LD
Government bodies contacted
3
Lobbying activity
1
S 4220 The Veterans Novel Therapeutics Act VET: S.4220 The Novel Therapeutics Act and educate on PTSD therapies
Bills named in this filing
1